miR Scientific: spotting aggression with RNA in urine

miR has paired its panel of urine-based RNAs with a statistical algorithm for accurate diagnosis of aggressive bladder and prostate cancers, sparing patients with lower-grade tumors from invasive biopsies and unnecessary drug treatments.

The company's technology, which was spun out of the State University of New York University at Albany, is based on work by co-founder and CSO Martin Tenniswood that ties expression level of specific small non-coding RNA (sncRNA) sequences to cancer biology. Tenniswood is the director of the Cancer Research Center at SUNY Albany...